drugset / Trial / NCT00787007

Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers

NCT00787007

Phase 1 Completed 60 enrolled Ausio Pharmaceuticals, LLC
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is 1) to test the safety of S-equol in healthy volunteers and 2) to see how quickly S-equol enters the bloodstream, is distributed in the body, and broken down and removed, when taken with food or without food.

Timeline

Start
2008-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AUS-131 Small molecule 10 mg Oral
Subject AUS-131 Small molecule 20 mg Oral
Subject AUS-131 Small molecule 40 mg Oral
Subject AUS-131 Small molecule 80 mg Oral
Subject AUS-131 Small molecule 160 mg Oral
Subject AUS-131 Small molecule 320 mg Oral

Indications

No indication recorded.